Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433999
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-05-23
Brief Title:
A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis
Sponsor:
Priovant Therapeutics Inc
Organization:
Priovant Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-23
First Submit QC Date:
May 23 2024
Study First Post Date:
2024-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-16
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL